Millipore Sigma Vibrant Logo

324515 eEF-2 Kinase Inhibitor, NH125 - CAS 278603-08-0 - Calbiochem

The eEF-2 Kinase Inhibitor, NH125, also referenced under CAS 278603-08-0, controls the biological activity of eEF-2 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: 1-Benzyl-3-cetyl-2-methylimidazolium iodide, 1-Cetyl-3-benzyl-2-methylimidazolium iodide, CaM-Dependent Kinase III Inhibitor, NH125

Primary Target: Bacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 (elongation factor 2) kinase/CaMKIII
View Products on Sigmaaldrich.com
324515
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
278603-08-0C₂₇H₄₅IN₂

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
324515-5MG
Retrieving availability...
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 5 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable imidazolium compound that inhibits the activity of bacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 (elongation factor 2) kinase/CaMKIII (IC50 = 60 nM), while exhibiting much lower potency against PKC, PKA, and CaMKII (IC50 = 7.5, 80, and >100 µM, respectively). NIH125 is a known P-gp substrate, which limits its in vivo efficacy as an anticancer and antimicrobial agent.
      Catalogue Number324515
      Brand Family Calbiochem®
      Synonyms1-Benzyl-3-cetyl-2-methylimidazolium iodide, 1-Cetyl-3-benzyl-2-methylimidazolium iodide, CaM-Dependent Kinase III Inhibitor, NH125
      References
      ReferencesArora, S., et al. 2004. Mol. Pharmacol. 66, 460.
      Arora, S., et al. 2003. Cancer Res. 63, 6894.
      Yamamoto, K., et al. 2000. Biosci. Biotechnol. Biochem. 64, 919.
      Product Information
      CAS number278603-08-0
      ATP CompetitiveN
      FormWhite to yellow solid
      Hill FormulaC₂₇H₄₅IN₂
      Chemical formulaC₂₇H₄₅IN₂
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetBacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 (elongation factor 2) kinase/CaMKIII
      Primary Target IC<sub>50</sub>60 nM against the activity of bacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 (elongation factor 2) kinase/CaMKIII
      Purity≥95% by NMR
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38

      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-36

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      324515-5MG 04055977197303

      Documentation

      eEF-2 Kinase Inhibitor, NH125 - CAS 278603-08-0 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      eEF-2 Kinase Inhibitor, NH125 - CAS 278603-08-0 - Calbiochem Certificates of Analysis

      TitleLot Number
      324515

      References

      Reference overview
      Arora, S., et al. 2004. Mol. Pharmacol. 66, 460.
      Arora, S., et al. 2003. Cancer Res. 63, 6894.
      Yamamoto, K., et al. 2000. Biosci. Biotechnol. Biochem. 64, 919.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-August-2023 JSW
      Synonyms1-Benzyl-3-cetyl-2-methylimidazolium iodide, 1-Cetyl-3-benzyl-2-methylimidazolium iodide, CaM-Dependent Kinase III Inhibitor, NH125
      DescriptionA cell-permeable imidazolium compound that inhibits the activity of bacterial histidine kinases (EnvZ, PhoQ, BvgS, and EvgS) and eukaryotic eEF-2 (elongation factor 2) kinase/CaMKIII (IC50 = 60 nM), while exhibiting much lower potency against PKC, PKA, and CaMKII (IC50 = 7.5, 80, and >100 µM, respectively). NIH125 is a known P-gp substrate, which limits its in vivo efficacy as an anticancer and antimicrobial agent.
      FormWhite to yellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number278603-08-0
      Chemical formulaC₂₇H₄₅IN₂
      Structure formulaStructure formula
      Purity≥95% by NMR
      SolubilityDMSO (20 mg/ml) or 70% Ethanol (5 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Irritant
      ReferencesArora, S., et al. 2004. Mol. Pharmacol. 66, 460.
      Arora, S., et al. 2003. Cancer Res. 63, 6894.
      Yamamoto, K., et al. 2000. Biosci. Biotechnol. Biochem. 64, 919.